Concepedia

Elizaveta A. Andrianova

EA

Statistics

Publications

3

Citations

1.3K

H-Index

3

Active since

2012

Affiliations

Moderna Therapeutics (United States)(Current)

Elizaveta A. Andrianova is an author at Moderna Therapeutics (United States) specializing in gene expression, life sciences, and nanoparticle design.

Publications per year

2012–2024

3

Publications

3

Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

Jeffrey S. Hrkach, Daniel D. Von Hoff, Mir Mukkaram Ali et al. · Science Translational Medicine · 2012 · 1.1K citations

, , +17

MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct

Ruchi Jain, Josh P. Frederick, Eric Yi‐Hsiu Huang et al. · Nucleic Acid Therapeutics · 2018 · 162 citations · Full text

, , +17

Attenuating ribosome load improves protein output from mRNA by limiting translation-dependent mRNA decay

Alicia A. Bicknell, David W. Reid, Marissa C. Licata et al. · Cell Reports · 2024 · 66 citations · Full text

, , +17

1–3 of 3